The effect of leflunomide on the eye dryness in secondary Sjögren’s syndrome associated with rheumatoid arthritis and in rheumatoid arthritis patients

The Important Role of T Cells and Receptor Expression in Sjögren's Syndrome

(2013) A. Karabiyik et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

American College of Rheumatology classification criteria for Sjögren's syndrome: A data-driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance Cohort

(2012) S. C. Shiboski et al.   ARTHRITIS CARE & RESEARCH

Sjögren Syndrome or Sjögren Disease? The Histological and Immunological Bias Caused by the 2002 Criteria

(2009) Manuel Ramos-Casals et al.   CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY

Nécroses cutanées induites par le léflunomide

(2008) C. Gros et al.   ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE

Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate

(2008) G Wells et al.   ANNALS OF THE RHEUMATIC DISEASES

Leflunomide-induced toxic epidermal necrolysis in a patient with rheumatoid arthritis

(2008) Hasna Hassikou et al.   JOINT BONE SPINE